Biotech IPO And Market Slide
Nordic Bioscience IPO hinges on obesity trial data while global equities slide amid AI capex fears and geopolitical uncertainty.
Get a push when something new happens here — high-importance only.
- Velocity0.4/day
- Sources0
- Markets5
- MARKETMETA.O (META.O)
▲ 8.90% close $612.10 from $562.05
- MARKETWarsh vows to tame inflation, insists Fed remains independent despite White House pressure
Federal Reserve Chair Kevin Warsh signaled a hawkish stance on price stability while defending the central bank's autonomy from political interference.
- MARKETNovo Nordisk shares slide as major shareholder slams governance
A prominent investor has accused the pharma giant's board of "extremely poor governance," triggering early selling pressure in Copenhagen.
- MARKETNordic Bioscience IPO hinges on Novo Nordisk rival's weight-loss data
The Danish biotech firm's path to a public listing depends on upcoming trial results that could validate its obesity treatment pipeline.
- EVENTGlobal equities slide as AI capex fears and geopolitical uncertainty weigh on sentiment
Selling pressure spread from US markets to Asia and Europe, driven by concerns over massive tech spending and ongoing Middle East tensions.